Log In
BCIQ
Print this Print this
 

S-488210

  Manage Alerts
Collapse Summary General Information
Company OncoTherapy Science Inc.
DescriptionCancer peptide vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationHead and neck cancer
Indication DetailsTreat head and neck squamous cell carcinoma (HNSCC)
Regulatory Designation
PartnerShionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today